torzelip
zentiva k.s. - ezetimibas/atorvastatinas - tabletės - 10 mg/80 mg - atorvastatin and ezetimibe
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hipofizės ir hipotalaminiai hormonai ir analogai - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
extrotan
egis pharmaceuticals plc - atorvastatinas/ezetimibas - kietosios kapsulės - 10 mg/10 mg - atorvastatin and ezetimibe
extrotan
egis pharmaceuticals plc - atorvastatinas/ezetimibas - kietosios kapsulės - 20 mg/10 mg - atorvastatin and ezetimibe
extrotan
egis pharmaceuticals plc - atorvastatinas/ezetimibas - kietosios kapsulės - 40 mg/10 mg - atorvastatin and ezetimibe
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antinavikiniai vaistai - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.